Not yet recruiting
Hairy cell leukaemia+1
Not yet recruitingPhase 2 Trial of Vemurafenib, Venetoclax and Rituximab in Relapsed or Refractory Hairy Cell Leukemia
Registered drugNo placebo
Phase 2 Trial of Vemurafenib, Venetoclax and Rituximab in Relapsed or Refractory Hairy Cell Leukemia
Registered drugNo placebo
- Disease:Hairy cell leukaemiaHairy cell leukaemia recurrent
- Substances:RituximabVemurafenib+1
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Rituximab
- Sponsor:Azienda Ospedaliera Di Perugia
